Regis Healthcare (REG) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
15 Dec, 2025Executive summary
Revenue from services rose 17.5% to AUD 564.2 million for H1 FY25, with underlying EBITDA up 31% to AUD 68.1 million and net profit after tax up 301% to AUD 24.4 million, driven by higher occupancy, government funding, and acquisitions.
Mature homes average occupancy increased to 95.7%, with spot occupancy at 96%, and improved star ratings and care minutes delivered.
Strategic focus on expanding residential aged care footprint through acquisitions, developments, and home care, leveraging technology for operational efficiency.
Continued investment in workforce, safety, and clinical care, resulting in improved care indicators and reduced injury rates.
Net cash position improved to AUD 179.9 million, and an interim dividend of 8.09 cents per share (60% franked) was declared.
Financial highlights
Net operating cash flow was AUD 208.6 million, up 37%, including AUD 73.3 million in government funding received in advance.
Underlying EBIT surged 522.9% to AUD 44.4 million; underlying EBITDA margin increased to 12.1%.
Net RAD cash inflow doubled to AUD 85.8 million; capital expenditure was AUD 32.7 million, focused on development and refurbishment.
Basic EPS was 8.09 cents, up from a loss of 4.03 cents per share in H1 FY24.
Interim dividend of AUD 0.0809 per share, 60% franked, representing 100% of net profit after tax.
Outlook and guidance
Expecting continued high occupancy (96%+) in mature homes for the second half of FY25.
Anticipate increased government funding from 1 March 2025 to fully cover Fair Work nurse wage increases.
CapEx for the full year projected at AUD 35–40 million, reflecting ongoing refurbishments and developments.
Government reforms and new Aged Care Act (effective 1 July 2025) expected to improve funding and provider returns.
Strong balance sheet and undrawn debt facilities support aggressive pursuit of growth initiatives.
Latest events from Regis Healthcare
- Revenue up 18.4% and underlying EBITDA up 3.7%, with acquisitions and reforms fueling growth.REG
H1 202623 Feb 2026 - Record revenue and EBITDA growth, high occupancy, and strong cash flow amid sector reforms.REG
H2 202423 Jan 2026 - Strong financial growth, strategic expansion, and high shareholder approval highlighted the AGM.REG
AGM 202412 Jan 2026 - Revenue, EBITDA, and NPAT rose sharply, supported by acquisitions and high occupancy.REG
H2 202523 Nov 2025 - Strong financial growth, expansion plans, and all resolutions passed with high support.REG
AGM 202518 Nov 2025